|
市場調査レポート
商品コード
1353414
ポイントオブケア超音波の世界市場規模、シェア、産業動向分析レポート:エンドユーザー別、製品別、地域別展望と予測、2023年~2030年Global Point-of-care Ultrasound Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Clinics, and Others), By Product (Cart-based, and Compact & Hand-held), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
ポイントオブケア超音波の世界市場規模、シェア、産業動向分析レポート:エンドユーザー別、製品別、地域別展望と予測、2023年~2030年 |
出版日: 2023年08月31日
発行: KBV Research
ページ情報: 英文 274 Pages
納期: 即納可能
![]() |
ポイントオブケア超音波市場規模は、予測期間中にCAGR 13.8%で成長し、2030年には32億米ドルに達すると予測されます。2022年の市場規模は1,60,085.6台、成長率は14.7%(2019-2022年)。
KBVカーディナルマトリックスに示された分析によると、日立製作所が同市場における先駆者です。2020年3月、日立製作所はARIETTAの超音波診断プラットフォームシリーズの新モデルARIETTA 750を発表しました。この先進的な超音波プラットフォームは、様々な治療現場のニーズに適応します。GE HealthCare Technologies, Inc.、FUJIFILM Sonosite, Inc.、Shenzhen Mindray Bio-Medical Electronics Co.Ltd.などの企業が、この市場における主要なイノベーターです。
COVID-19影響分析
COVID-19パンデミックは渡航制限や国の閉鎖により、全世界の人々のヘルスケアへのアクセスを妨げました。しかし、COVID-19の流行後、世界中の患者の間で画像診断検査が増加したため、市場は大きく成長しました。その結果、ベッドサイドでの画像診断検査は、汚染のリスクを減らすことによってCOVID-19を制御するために不可欠な要素となっています。COVIDの大流行の結果、肺超音波検査の実施件数が増加しました。これらの検査は、COVID-19患者に併発する呼吸器疾患の同定、肺病変の重症度評価、病理学的変化の評価に利用されました。F
市場成長要因
主要参入企業による超音波装置の発売重視
携帯性、大幅なコスト削減、臨床効果の向上などの利点から、ポイントオブケア用超音波診断装置の需要は、ヘルスケア専門分野全体で増加し続けています。ルワンダの病院で実施されたコホート調査では、ポイントオブケア超音波が主に投薬(42.4%)と体位(30%)を改善していることが判明しました。さらに、市場参入企業は、発展途上国におけるポイントオブケア用途の超音波装置の発売と開拓に大きな関心を寄せており、これが超音波装置へのアクセスや普及を後押しし、市場拡大に拍車をかけています。
この分野における技術進歩の増加
予想される期間を通じて、市場拡大の機会は数多く存在します。これは、心エコー、心嚢穿刺、胸腔穿刺、断層撮影、バスキュラーアクセス、関節穿刺などの手技における技術進歩や、業務効率と患者の健康状態を改善するための静脈カテーテル検査や末梢静脈カテーテル検査のようなモバイルポイントオブケア機器に対する需要の高まりによるものです。さらに、市場拡大の可能性は、ポイントオブケア超音波装置の使用を促進し、さまざまな分野の専門家を教育するために、さまざまな組織が開始したマーケティング活動によって後押しされています。さらに、医師は心停止の評価にPOCUSを採用することが多いです。このような進歩は、今後数年間の市場の成長を保証すると思われます。
市場抑制要因
ポイント・オブ・ケア・アプリケーションにおけるポータブル機器の限界
これらのガジェットの採用に関する懸念は、ハンドヘルド機器の使用に関する制限から生じる。LumifyやVscan Airなど、すでに市場に出回っている超音波装置は、心臓血管の問題や個人の外傷など、特定の病気を診断するために作られています。そのため、これらのツールは、3Dや4D画像だけでなく、患者の身体検査の他の要素をサポートすることはできません。さらに、感度や特異度の低さ、画質の遅れ、装置の小型化などの要因により、患者の病気の診断や臨床的進行に限界が生じる可能性があります。さらに、これらの機器を使用するためのトレーニングや認証プログラムが国内および国際機関によって提供されていないことも、市場の抑制要因となっています。
エンドユーザーの展望
エンドユーザー別に見ると、市場は病院、診療所、その他に3分されます。診療所セグメントは2022年の市場で大きな収益シェアを獲得しました。クリニックでPOCUSの利用が拡大している主な要因は、合併症を早期に発見できればヘルスケアコストを節約できる可能性があることです。臨床医はPOCUSを使用して、中心静脈ライン留置、胸腔穿刺、副鼻腔穿刺、関節吸引などのさまざまな医療手技をガイドし、精度を確保するとともに合併症のリスクを低減することができます。
製品展望
製品別では、市場はカートベースとコンパクト&ハンドヘルドに区分されます。2022年には、カートベースのセグメントが最大の売上高シェアで市場を独占しました。カートベースのシステムには、カラードップラー、スペクトルドップラー、3D/4Dイメージング、エラストグラフィなどの高度なイメージング機能が搭載されていることが多く、より包括的な診断評価が可能です。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が市場で最も高い収益シェアを記録しました。最先端かつ小型の超音波装置を発売する大手企業が市場成長の要因となっています。また、医療従事者によるポイントオブケア用途での超音波装置の採用が増え続けていることも、北米の市場拡大に寄与しています。技術革新、臨床上のメリット、教育機会、規制当局のサポートが相まって、北米全域でPOCUSの利用が増加しています。
The Global Point-of-care Ultrasound Market size is expected to reach $3.2 billion by 2030, rising at a market growth of 13.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,60,085.6 units, experiencing a growth of 14.7% (2019-2022).
Medical professionals utilize smaller equipment to diagnose respiratory diseases and injuries at the patient's bedside in intensive care units and emergency departments. Thus, the Compact & Hand-held segment will register approximately half of the share of the market by 2030. According to data released by National Health Service (NHS) England, 10.3 million ultrasound procedures were carried out in the U.K. in 2020. Portable, safe, and cost-effective small and hand-held technologies provide rapid outcomes for clinical decision-making. Furthermore, compared to traditional ultrasound machines, expenses for handheld devices are cheaper. The widespread acceptance of these devices was due to their prospective benefits, including non-invasiveness, high sensitivity, and rapid ultrasound interpretation across health centers.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The device offers a novel and adjustable work surface, to increase clinician ergonomics and productivity. Additionally, In November, 2022, Philips released the compact 5000 series. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Based on the Analysis presented in the KBV Cardinal matrix; Hitachi, Ltd. is the forerunner in the Market. In March, 2020, Hitachi, Ltd. revealed ARIETTA 750, the new model from the ARIETTA's diagnostic ultrasound platform series. This advanced ultrasound platform adapts to the needs of varied therapeutic settings. Companies such as GE HealthCare Technologies, Inc., FUJIFILM Sonosite, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are some of the key innovators in the Market.
COVID-19 Impact Analysis
Due to travel restrictions and national lockdowns, the COVID-19 pandemic hampered access to healthcare for the entire world's population. However, the market saw significant growth after the COVID-19 outbreak due to a rise in diagnostic imaging testing among patients across the globe. a result, bedside diagnostic imaging became an essential component of controlling COVID-19 by reducing the risk of contamination. As a result of the COVID pandemic, there was an increase in the number of lung ultrasound tests performed. These tests were utilized to identify co-occurring respiratory pathologies in COVID-19 patients, assess the severity of lung pathology, and evaluate pathological changes. F
Market Growth Factors
Emphasis on ultrasound device launches by major participants
Due to advantages such as portability, significantly cheaper cost, and increased clinical efficacy of these devices, the demand for ultrasound equipment for point-of-care applications continues to rise across healthcare specialties. In cohort research conducted in Rwanda hospitals, it was found that point-of-care ultrasound primarily modified the medications delivered (42.4%) and the disposition (30%). Furthermore, market participants focus a lot of attention on the launch and development of ultrasound devices in point-of-care applications in developing countries, which boosts ultrasound device accessibility and adoption, thereby fueling market expansion.
Increasing Technological advancements in the field
There are numerous opportunities for the market to expand throughout the anticipated period. This is due to technological advancements in procedures like echocardiography, pericardiocentesis, thoracentesis, tomography, vascular access, and arthrocentesis as well as the rising demand for mobile point-of-care devices like venous catheterization and peripheral venous catheterization to improve operational efficiency and patient health. Additionally, market expansion potential is fueled by marketing efforts launched by various organizations to promote the use of point-of-care ultrasound devices and educate professionals from various fields. Furthermore, doctors often employ POCUS to evaluate cardiac arrests. Such advances would guarantee the market's growth in the coming years.
Market Restraining Factors
Limitations of portable devices in point-of-care applications
Concerns about adopting these gadgets arise from the restrictions related to using hand-held devices. The ultrasound machines already in the market, such as Lumify and Vscan Air, are made to diagnose certain illnesses, like cardiovascular problems and trauma in individuals. Therefore, these tools cannot support 3D and 4D imaging as well as other components of the patient's physical examination. Furthermore, limitations in the diagnosis and clinical progression of diseases among patients may be caused by factors like low sensitivity and specificity, delayed image quality, and small devices. Additionally, the market is being constrained by the absence of training and certification programs offered by national and international organizations for using these devices.
End User Outlook
Based on end user, the market is trifurcated into hospitals, clinics, and others. The clinics segment garnered a significant revenue share in the market in 2022. The key driver of POCUS's growing use in clinics is the potential to save healthcare costs if complications are detected early. Clinicians can use POCUS to guide various medical procedures, such as central line placements, thoracentesis, paracentesis, and joint aspirations, ensuring precision and reducing the risk of complications.
Product Outlook
By product, the market is segmented into cart-based and compact & hand-held. In 2022, the cart-based segment dominated the market with the maximum revenue share. Cart-based systems often come equipped with a range of advanced imaging features, including color Doppler, spectral Doppler, 3D/4D imaging, and elastography, enabling more comprehensive diagnostic evaluations.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. Leading companies launching cutting-edge and small ultrasound equipment are responsible for the market's growth. The adoption of ultrasound equipment for point-of-care applications by medical professionals, which continues to rise, also contributed to the market expansion in North America. The combination of technological innovation, clinical benefits, educational opportunities, and regulatory support has fueled the increasing use of POCUS across North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Alpinion Medical Systems Co., Ltd. (ILJIN Group), Hitachi, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terason, Healcerion Co., Ltd., Edan Instruments, Inc. and Chilson Medical Technologies Co., Ltd.
Recent Strategies Deployed in Point-of-care Ultrasound Market
Partnerships, Collaboration and Agreements:
Sep-2021: GE Healthcare joined hands with UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI. The images of an astronaut's heart in microgravity would be captured using the real-time AI guidance software of UltraSight and the portable GE Vscan AirTM, a high-performance, wireless pocket-sized color ultrasound from GE Healthcare.
Jan-2021: Hitachi entered into an agreement with Olympus Corporation, a manufacturer of optics and reprography products. With this agreement, the company aimed to offer better diagnostic and treatment to patients and healthcare professionals.
Product Launch and Product Expansions:
Jan-2023: FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The newest version of Sonosite POCUS, called Sonosite PX, offers the highest level of visual quality ever seen in a Sonosite system, as well as a number of features that help with workflow efficiency and a flexible form factor. The device offers a novel and adjustable work surface that can be employed in a horizontal or vertical position depending on the situational needs of the exam in order to increase clinician ergonomics and productivity.
Nov-2022: Philips released the compact 5000 series, a new compact ultrasound system. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Jun-2022: Mindray unveiled TEX20 Series, best-in-class Point of Care ultrasound system. With its patient-centered information solution, extraordinary image clarity, clinically oriented workflow, smart tools, and intelligent design, this ground-breaking point of care system, the TEX20 Series, dramatically alters the conventional perspective of POC ultrasonography from its predecessors. It offers all the details needed to make decisions for follow-up and quality control.
Mar-2021: GE Healthcare today unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging. The Venue Fit is the smallest system in the Venue Family from GE Healthcare, with a tiny footprint designed to fit in confined places, an easy-to-clean touchscreen, and straightforward scanning tools. The new Venue Fit ultrasound device enables healthcare professionals who work in constrained areas to get immediate imaging insights.
Mar-2021: GE Healthcare Vscan Air, hand-held ultrasound device. The new product is completely wireless, links to a smartphone app, and enables patients to safely access the images. Trained healthcare professionals can use the gadget to immediately test blood flow, gallbladder illness, and analyze and monitor Covid-19 through a lung exam.
Mar-2021: ALPINION MEDICAL SYSTEMS launched X-CUBE 90, High-Performance Ultrasound Diagnostic System. ALPINION separately created the imaging platform known as X+ Architecture, which is used in X-CUBE 90. Large-size data are quickly reorganized using the special algorithm used by ALPINION, resulting in the production of clear, high-resolution photographs.
Acquisitions and Merger:
Jul-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced an agreement to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH. Through this acquisition, Mindray would significantly strengthen its international supply chain infrastructure and assist the expansion of our IVD business into medium- to large-sized customer sectors. Both companies will work together to realize synergies and increase value for our customers.
Sep-2021: GE Healthcare completed the acquisition of BK Medical, a company that offers ultrasound technology. The acquisition would help GE Healthcare expand its ultrasound offerings into surgical visualization and fuel the growth in precision health.
Market Segments covered in the Report:
By End User (Volume, Units, USD Million, 2019-2030)
By Product (Volume, Units, USD Million, 2019-2030)
By Geography (Volume, Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research